BMS-986253
Showing 1 - 25 of 819
MDS Trial run by the National Cancer Institute (NCI) (decitabine and cedazuridine, BMS-986253)
Not yet recruiting
- Myelodysplastic Syndromes
- decitabine and cedazuridine
- BMS-986253
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 17, 2022
Head and Neck Squamous Cell Carcinoma Trial in Baltimore (Nivolumab, HuMax-IL8, Cabiralizumab)
Recruiting
- Head and Neck Squamous Cell Carcinoma
- Nivolumab
- +2 more
-
Baltimore, MarylandJohns Hopkins University
Jul 28, 2022
Hepatocellular Carcinoma Trial in New York, Philadelphia (Nivolumab 240 mg IV every 2 weeks + Cabiralizumab 4 mg/kg IV every 2
Recruiting
- Hepatocellular Carcinoma
- Nivolumab 240 mg IV every 2 weeks + Cabiralizumab 4 mg/kg IV every 2 weeks
- +2 more
-
New York, New York
- +1 more
Nov 1, 2021
NSCLC, Hepatocellular Carcinoma Trial in New York (Nivolumab, BMS-813160, BMS-986253)
Recruiting
- Non-small Cell Lung Cancer
- Hepatocellular Carcinoma
- Nivolumab
- +2 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Oct 14, 2021
Solid Tumor, Sars-CoV2, Hematological Malignancy Trial in New York (BMS-986253)
Terminated
- Solid Tumor
- +2 more
- BMS-986253
-
New York, New YorkColumbia University Irving Medical Center
Nov 18, 2021
Cancer, Melanoma Trial in Worldwide (drug, biological, other)
Recruiting
- Cancer
- Melanoma
- BMS-986253
- +3 more
-
Springdale, Arkansas
- +70 more
May 16, 2022
Calcium Citrate Absorption, Calcium Carbonate Absorption Trial in Alexandria (The absorption effect between calcium citrate and
Not yet recruiting
- Calcium Citrate Absorption
- Calcium Carbonate Absorption
- The absorption effect between calcium citrate and calcium carbonate
-
Alexandria, EgyptThe surgical department of Medical Research Institute Hospital,
Sep 15, 2023
Burning Mouth Syndrome Trial (drug, other, dietary supplement, radiation)
Not yet recruiting
- Burning Mouth Syndrome
- topical placebo tablet
- +5 more
- (no location specified)
Sep 10, 2023
Pulmonary Fibrosis Trial in Worldwide (BMS-986278 Placebo, BMS-986278)
Active, not recruiting
- Pulmonary Fibrosis
- BMS-986278 Placebo
- BMS-986278
-
Birmingham, Alabama
- +118 more
Dec 3, 2022
Burning Mouth Syndrome Trial in Catania (Diazepam 1% oral gel, Placebo)
Recruiting
- Burning Mouth Syndrome
- Diazepam 1% oral gel
- Placebo
-
Catania, ItalyAOU Policlinico G. Rodolico
May 23, 2023
Relapsed and/or Refractory Multiple Myeloma Trial in Köln (BMS-986453, Fludarabine, Cyclophosphamide)
Not yet recruiting
- Relapsed and/or Refractory Multiple Myeloma
- BMS-986453
- +2 more
-
Köln, GermanyLocal Institution - 0017
Dec 4, 2023
Progressive Pulmonary Fibrosis Trial in Worldwide (BMS-986278, BMS-986278 Placebo)
Not yet recruiting
- Progressive Pulmonary Fibrosis
- BMS-986278
- BMS-986278 Placebo
-
Stanford, California
- +7 more
Sep 11, 2023
Idiopathic Pulmonary Fibrosis Trial in Worldwide (BMS-986278, BMS-986278 Placebo)
Not yet recruiting
- Idiopathic Pulmonary Fibrosis
- BMS-986278
- BMS-986278 Placebo
-
Birmingham, Alabama
- +442 more
Aug 15, 2023
Metastatic Castration-resistant Prostate Cancer Trial in United States (BMS-986460)
Recruiting
- Metastatic Castration-resistant Prostate Cancer
-
Palo Alto, California
- +7 more
Oct 10, 2023
Healthy Participants Trial in Cypress (BMS-986446, Placebo)
Not yet recruiting
- Healthy Participants
- BMS-986446
- Placebo
-
Cypress, CaliforniaAltasciences
Oct 10, 2023
Diabetic Foot Trial in Durham (Bluedrop Monitoring Service (BMS))
Not yet recruiting
- Diabetic Foot
- Bluedrop Monitoring Service (BMS)
-
Durham, North CarolinaDuke Clinical Research Institute
Sep 12, 2023
Healthy Volunteers Trial in City (BMS-986325, Placebo)
Not yet recruiting
- Healthy Volunteers
- BMS-986325
- Placebo
-
City, State, JapanLocal Institution
Apr 3, 2023